SCHEMBL2840634

SCHEMBL2840634

CN1Cc2sccc2C(Oc2cccc(Cl)c2Cl)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
DRD2 P14416 4/20 0.35
DRD3 P35462 1/20 0.35
SLC6A2 P23975 8/20 0.34
SLC6A4 P31645 8/20 0.34
SLC6A3 Q01959 7/20 0.34
HTR7 P34969 3/20 0.34
HTR6 P50406 3/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HTR1A P08908 1/20 0.33
HTR1D P28221 2/20 0.33
HTR1B P28222 2/20 0.33
DRD1 P21728 1/20 0.32
HTR2A P28223 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
AURKA O14965 1/20 0.31
AURKB Q96GD4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2837016 0.89 DRD1 (0.38) NPC1RAB9ADRD2DRD3HTR7
Hydrochloric Acid SCHEMBL2879094 0.88 DRD1 (0.38) NPC1RAB9ADRD2DRD3HTR7
Hydrochloric Acid SCHEMBL2837012 0.83 ALDH1A1 (0.38) DRD2SLC6A2SLC6A4SLC6A3HTR7
SCHEMBL2841182 0.81 SLC6A2 (0.37) NPC1RAB9ADRD2DRD3SLC6A2
Hydrochloric Acid SCHEMBL2875741 0.81 KDM4E (0.32) DRD2SLC6A2SLC6A4SLC6A3HTR7
SCHEMBL2841032 0.81 SLC6A2 (0.45) NPC1RAB9ADRD2DRD3SLC6A2
SCHEMBL2840332 0.80 SLC6A2 (0.40) NPC1RAB9ASLC6A2SLC6A4SLC6A3
SCHEMBL2839502 0.77 SLC6A2 (0.34) DRD2DRD3SLC6A2SLC6A4SLC6A3
SCHEMBL2841140 0.76 DRD2 (0.36) DRD2DRD3DRD1
SCHEMBL2843946 0.76 NPC1 (0.42) NPC1RAB9ASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 NPC1 1665/4885RAB9A 1933/4885DRD2 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.